BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1071448)

  • 1. Myelofibrosis in chronic myeloid leukemia (report of a case).
    Attal HC; Grover S; Dua HS
    J Assoc Physicians India; 1976 May; 24(5):327-31. PubMed ID: 1071448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Idiopathic myelofibrosis and secondary myelofibrosis in chromic myeloleukosis].
    Dul'tsin MS; Klimova NF; Cherntsova TA; Zakharova AV
    Probl Gematol Pereliv Krovi; 1967 Jan; 12(1):12-24. PubMed ID: 5245631
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-blastic meningeal leukemia during the myelofibrotic phase of chronic myeloid leukemia.
    Aversa P; Rambotti P; Falini B; Grignani F; Martelli MF
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):72-5. PubMed ID: 6164616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic crisis and myelofibrosis, simultaneous complications in a case of chronic myelocytic leukemia.
    Hassan K
    J Pak Med Assoc; 1981 Jul; 31(7):151-3. PubMed ID: 6792398
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myelofibrosis with myeloid metaplasia. The spectrum of clinical syndromes.
    Barosi G; Polino G
    Haematologica; 1987; 72(6):553-62. PubMed ID: 3126116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of chronic myelocytic leukemia].
    Krug K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):261-7. PubMed ID: 6168537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adenopathies in chronic myeloid leukemia (CML). Study of 161 cases].
    Paolino W; Infelise V; Degani G; Falda M; Paolino F; Fiorio C; Marmont F; Coda R
    Minerva Med; 1980 Aug; 71(30):2115-23. PubMed ID: 6933320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia.
    Licht A; Many N; Rachmilewitz EA
    Acta Haematol; 1973; 49(3):182-9. PubMed ID: 4198453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Femoral bone marrow in myelosclerosis].
    Waitz R; Mayer S; Mayer G; Oberling F
    Nouv Rev Fr Hematol; 1973; 13(3):416-21. PubMed ID: 4270598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
    Seewann HL; Jüttner F; Vykoupil KF
    Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary fibrosis and splenic erythroblastosis in chronic myeloid leukemia].
    Tanzer J; Najean Y; Jcquillat C; Ripault J; Chome J
    Nouv Rev Fr Hematol; 1967; 7(5):801-8. PubMed ID: 4230115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathological analysis in 37 cases on secondary myelofibrosis].
    Pan WS
    Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):213-5. PubMed ID: 3228914
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelofibrosis and megakaryoblastic transformation of chronic myelogenous leukemia associated with intrinsic platelet dysfunction: hematological, histological and ultrastructural findings.
    Cortelazzo S; D'Emilio A; Battista R; Ricciardi O; Dini E; Visonà A; Montaguti A; Pennelli N
    Haematologica; 1984; 69(6):671-81. PubMed ID: 6441743
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of the course of myelocytic leukemia associated with myelofibrosis].
    Klimova NF; Zakharova AV; Korenevskaia MI; Aksenova OV
    Probl Gematol Pereliv Krovi; 1975 Feb; 20(2):26-9. PubMed ID: 1059075
    [No Abstract]   [Full Text] [Related]  

  • 17. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
    Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
    Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined splenic scintigraphy and function test: a new differential diagnostic criterion in chronic myeloid leukemia and myelofibrosis].
    Roux A; Fischer J; León A; Wolf R
    Verh Dtsch Ges Inn Med; 1969; 75():510-3. PubMed ID: 5275880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.